Bollard Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.97M | Sell |
115,000
-11,294
| -9% | -$658K | 0.21% | 53 |
|
|
2025
Q4 | $6.81M | Sell |
126,294
-7,511
| -6% | -$361K | 0.17% | 52 |
|
|
2025
Q3 | $6.04M | Buy |
133,805
+5,297
| +4% | +$247K | 0.14% | 59 |
|
|
2025
Q2 | $5.95M | Buy |
128,508
+7,811
| +6% | +$383K | 0.14% | 58 |
|
|
2025
Q1 | $7.36M | Buy |
120,697
+1,019
| +0.9% | +$59.4K | 0.19% | 41 |
|
|
2024
Q4 | $6.77M | Sell |
119,678
-935
| -0.8% | -$52.2K | 0.19% | 44 |
|
|
2024
Q3 | $6.24M | Sell |
120,613
-14,689
| -11% | -$689K | 0.17% | 50 |
|
|
2024
Q2 | $5.62M | Buy |
135,302
+6,506
| +5% | +$291K | 0.16% | 49 |
|
|
2024
Q1 | $6.99M | Buy |
128,796
+2,819
| +2% | +$144K | 0.21% | 42 |
|
|
2023
Q4 | $6.46M | Sell |
125,977
-31,232
| -20% | -$1.64M | 0.22% | 43 |
|
|
2023
Q3 | $9.12M | Sell |
157,209
-11,063
| -7% | -$678K | 0.34% | 37 |
|
|
2023
Q2 | $10.8M | Buy |
168,272
+1,184
| +0.7% | +$79.4K | 0.37% | 39 |
|
|
2023
Q1 | $11.6M | Buy |
167,088
+887
| +0.5% | +$62.6K | 0.42% | 35 |
|
|
2022
Q4 | $12M | Sell |
166,201
-7,884
| -5% | -$594K | 0.46% | 34 |
|
|
2022
Q3 | $12.4M | Buy |
174,085
+874
| +0.5% | +$63.4K | 0.52% | 33 |
|
|
2022
Q2 | $13.3M | Buy |
173,211
+1,093
| +0.6% | +$83.2K | 0.54% | 33 |
|
|
2022
Q1 | $12.6M | Buy |
172,118
+11,747
| +7% | +$789K | 0.4% | 41 |
|
|
2021
Q4 | $10M | Buy |
160,371
+1,174
| +0.7% | +$68.9K | 0.32% | 50 |
|
|
2021
Q3 | $9.42M | Buy |
159,197
+8,246
| +5% | +$543K | 0.31% | 53 |
|
|
2021
Q2 | $10.1M | Buy |
150,951
+11,117
| +8% | +$725K | 0.32% | 46 |
|
|
2021
Q1 | $8.83M | Buy |
139,834
+820
| +0.6% | +$51K | 0.31% | 44 |
|
|
2020
Q4 | $8.62M | Buy |
139,014
+783
| +0.6% | +$48.1K | 0.32% | 44 |
|
|
2020
Q3 | $8.33M | Buy |
138,231
+481
| +0.3% | +$28.9K | 0.3% | 47 |
|
|
2020
Q2 | $8.1M | Buy |
137,750
+2
| +0% | +$120 | 0.32% | 48 |
|
|
2020
Q1 | $7.68M | Buy |
137,748
+576
| +0.4% | +$35.2K | 0.34% | 45 |
|
|
2019
Q4 | $8.8M | Buy |
137,172
+565
| +0.4% | +$32.4K | 0.29% | 52 |
|
|
2019
Q3 | $6.93M | Sell |
136,607
-54,230
| -28% | -$2.55M | 0.24% | 61 |
|
|
2019
Q2 | $8.65M | Sell |
190,837
-57,508
| -23% | -$2.68M | 0.3% | 48 |
|
|
2019
Q1 | $11.8M | Buy |
248,345
+27,745
| +13% | +$1.38M | 0.45% | 29 |
|
|
2018
Q4 | $11.5M | Buy |
220,600
+10,858
| +5% | +$583K | 0.51% | 25 |
|
|
2018
Q3 | $13M | Buy |
209,742
+8,828
| +4% | +$524K | 0.52% | 22 |
|
|
2018
Q2 | $11.1M | Buy |
200,914
+3,789
| +2% | +$205K | 0.51% | 25 |
|
|
2018
Q1 | $12.5M | Buy |
197,125
+6,771
| +4% | +$436K | 0.62% | 21 |
|
|
2017
Q4 | $11.7M | Sell |
190,354
-1,281
| -0.7% | -$80.1K | 0.56% | 23 |
|
|
2017
Q3 | $12.2M | Buy |
191,635
+3,634
| +2% | +$212K | 0.64% | 22 |
|
|
2017
Q2 | $10.5M | Buy |
188,001
+1,528
| +0.8% | +$83.1K | 0.57% | 28 |
|
|
2017
Q1 | $10.1M | Buy |
186,473
+13,425
| +8% | +$736K | 0.58% | 26 |
|
|
2016
Q4 | $10.1M | Buy |
173,048
+1,708
| +1% | +$93.4K | 0.66% | 21 |
|
|
2016
Q3 | $9.24M | Buy |
171,340
+677
| +0.4% | +$43.5K | 0.59% | 21 |
|
|
2016
Q2 | $12.6M | Buy |
170,663
+715
| +0.4% | +$50.5K | 0.86% | 12 |
|
|
2016
Q1 | $10.9M | Buy |
169,948
+825
| +0.5% | +$52K | 0.87% | 16 |
|
|
2015
Q4 | $11.6M | Buy |
169,123
+741
| +0.4% | +$49K | 0.96% | 15 |
|
|
2015
Q3 | $9.97M | Buy |
168,382
+918
| +0.5% | +$58.2K | 0.82% | 19 |
|
|
2015
Q2 | $11.1M | Buy |
167,464
+934
| +0.6% | +$61.6K | 0.84% | 18 |
|
|
2015
Q1 | $10.7M | Buy |
166,530
+4,590
| +3% | +$287K | 0.8% | 18 |
|
|
2014
Q4 | $9.56M | Buy |
161,940
+7,056
| +5% | +$398K | 0.84% | 18 |
|
|
2014
Q3 | $7.93M | Buy |
154,884
+8,415
| +6% | +$420K | 0.75% | 22 |
|
|
2014
Q2 | $7.11M | Buy |
146,469
+2,489
| +2% | +$123K | 0.69% | 24 |
|
|
2014
Q1 | $7.48M | Buy |
143,980
+355
| +0.2% | +$18.9K | 0.76% | 21 |
|
|
2013
Q4 | $7.63M | Buy |
143,625
+3,538
| +3% | +$180K | 0.84% | 19 |
|
|
2013
Q3 | $6.48M | Buy |
140,087
+25,676
| +22% | +$1.13M | 0.76% | 22 |
|
|
2013
Q2 | $5.11M | Buy |
+114,411
| New | +$4.97M | 0.98% | 27 |
|
Other funds holding BMY
VCM
VPM
Bollard Group's BMY Position: Q1 2026 in Review
Bollard Group reduced its Bristol-Myers Squibb (BMY) stake by 8.9% in Q1 2026, selling an estimated $658K and leaving 115,000 shares worth $6.97M. The position accounts for 0.21% of the portfolio, ranked #53.
Bollard Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.3M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Bollard Group held 115,000 shares of Bristol-Myers Squibb worth $6.97M as of Q1 2026.
- Bollard Group sold 11,294 Bristol-Myers Squibb shares in Q1 2026, an estimated $658K.
- Bristol-Myers Squibb made up 0.21% of Bollard Group's portfolio in Q1 2026, its #53 holding.
- Bollard Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Bollard Group's Bristol-Myers Squibb position peaked at $13.3M in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Bollard Group's 13F filing for Q1 2026, filed 14 May 2026.